[Interstitial lung diseases].
Interstitial lung diseases (ILD) are an heterogeneous group of inflammatory diseases characterized by an anatomical distortion of peripheral airways and interstitium, determined by a first stage of alveolitis and a following stage of fibrosis. Natural history of several ILD is characterized by slow and progressive destruction of alveolar-capillary functional units, often with respiratory failure and death. For their smoldering evolution and not specificity of symptoms (exertional dyspnea and cough) ILD may remain not diagnosed and not treated for a long time.
Divisione di Medicina Interna, IRCCS Casa Sollievo della Sofferenza, Opera di Padre Pio da Pietrelcina, San Giovanni Rotondo. g.mazzoccoli@tin.it
Gianluigi
G
Mazzoccoli
Stefano
S
Carughi
Angelo
A
De Cata
Antonio
A
Giuliani
Nunzia
N
Masciale
Marco
M
La Viola
Felice
F
Puzzolante
Mario
M
Balzanelli
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D019867:Anti-Glomerular Basement Membrane Disease / Q000628:therapy; D001706:Biopsy; D001999:Bronchoscopy; D018549:Cryptogenic Organizing Pneumonia / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D008168:Lung / Q000000981:diagnostic imaging / Q000473:pathology; D017563:Lung Diseases, Interstitial / Q000145:classification / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000209:etiology / Q000473:pathology / Q000628:therapy; D016040:Lung Transplantation; D008875:Middle Aged; D010956:Plasmapheresis; D013902:Radiography, Thoracic; D011877:Radionuclide Imaging; D012129:Respiratory Function Tests; D012307:Risk Factors; D017565:Sarcoidosis, Pulmonary / Q000628:therapy; D014057:Tomography, X-Ray Computed
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents